CLINICAL TRIALS PROFILE FOR PLENVU
✉ Email this page to a colleague
All Clinical Trials for plenvu
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT03437265 ↗ | A Pharmacokinetic Study of PLENVU® in Healthy Subjects | Completed | Quotient Clinical | Phase 1 | 2020-09-03 | This study characterises the pharmacokinetic (PK) profile of the active ingredients of PLENVU (NER1006) and their related substances/metabolites. Subjects will receive PLENVU. |
| NCT03437265 ↗ | A Pharmacokinetic Study of PLENVU® in Healthy Subjects | Completed | Quotient Sciences | Phase 1 | 2020-09-03 | This study characterises the pharmacokinetic (PK) profile of the active ingredients of PLENVU (NER1006) and their related substances/metabolites. Subjects will receive PLENVU. |
| NCT03437265 ↗ | A Pharmacokinetic Study of PLENVU® in Healthy Subjects | Completed | Norgine | Phase 1 | 2020-09-03 | This study characterises the pharmacokinetic (PK) profile of the active ingredients of PLENVU (NER1006) and their related substances/metabolites. Subjects will receive PLENVU. |
| NCT03742232 ↗ | Study Comparing the Bowel Cleansing Efficacy of PLENVU® Versus SELG-ESSE® Using a 2-Day Split Dosing Regimen. | Completed | Istituto Clinico Humanitas | Phase 4 | 2018-10-31 | This study is a multicentre randomized parallel group phase IV study comparing the bowel cleansing efficacy, safety and tolerability of PLENVU® (a 1 litre PEG Bowel Cleansing Solution) versus SELG-ESSE® (a 4 litre PEG Bowel Cleansing Solution) using a 2-Day Split Dosing Regimen. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for plenvu
Condition Name
Clinical Trial Locations for plenvu
Clinical Trial Progress for plenvu
Clinical Trial Phase
Clinical Trial Sponsors for plenvu
Sponsor Name
